La Jolla Pharmaceutical Co (LJPC)

3.79 -0.08  -2.07% NASDAQ Jul 23, 20:00 USD
View Full Chart
Price Chart
View All LJPC News

News

View All Events

Events

Date Type Description
08/06/2021 Earnings Results Q2 2021 Earnings Results
05/07/2021 Earnings Results Q1 2021 Earnings Results
03/08/2021 Earnings Results Q4 2020 Earnings Results
11/09/2020 Earnings Results Q3 2020 Earnings Results
08/06/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: La Jolla Pharmaceutical Co is an American biopharmaceutical company. The company's main activity is the discovery, development, and commercialization of innovative therapies that improve patients' life-threatening conditions. The company's portfolio consists of an angiotensin II formulation, which regulates blood pressure; a formulation of hepcidin, an endogenous peptide hormone that regulates iron metabolism; and an antibiotic approved by the U.S. Food and Drug Administration.
  • URL: http://www.ljpc.com
  • Investor Relations URL: http://lajollapharmaceutical.com/investor-relations/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 07, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.